Oncternal Therapeutics, Inc. (ONCT)
Dec 3, 2024 - ONCT trading suspended
0.527
-0.167 (-24.12%)
Inactive · Last trade price
on Dec 2, 2024
Oncternal Therapeutics Employees
As of December 31, 2023, Oncternal Therapeutics had 30 total employees, including 27 full-time and 3 part-time employees. The number of employees decreased by 3 or -9.09% compared to the previous year.
Employees
30
Change (1Y)
-3
Growth (1Y)
-9.09%
Revenue / Employee
$72,033
Profits / Employee
-$1,152,500
Market Cap
1.56M
Employees Chart
ONCT News
- 5 months ago - Oncternal Therapeutics, Inc. (ONCT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Oncternal Therapeutics to Present in JonesTrading Healthcare Summit - GlobeNewsWire
- 7 months ago - Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer - GlobeNewsWire
- 8 months ago - Oncternal Therapeutics, Inc. (ONCT) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results - GlobeNewsWire